Authors: Djurovic, S Os, I Hofstad, AE Abdelnoor, M Westheim, A Berg, K

Citation: S. Djurovic et al., Increased plasma concentrations of TGF-beta(1) after hormone replacement therapy (vol 247, pg 279, 2000), J INTERN M, 249(3), 2001, pp. 271-271

Authors: Os, I Hofstad, AE Brekke, M Abdelnoor, M Nesheim, BI Jacobsen, AF Birkeland, K Larsen, A Midtbo, K Westheim, A

Citation: I. Os et al., The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized studyof the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins, J INTERN M, 247(4), 2000, pp. 433-441

Authors: Djurovic, S Os, I Hofstad, AE Abdelonoor, M Westheim, A Berg, K

Citation: S. Djurovic et al., Increased plasma concentrations of TGF-beta(1) after hormone replacement therapy, J INTERN M, 247(2), 2000, pp. 279-285

Authors: Seljeflot, I Arnesen, H Hofstad, AE Os, I

Citation: I. Seljeflot et al., Reduced expression of endothelial cell markers after long-term transdermalhormone replacement therapy in women with coronary artery disease, THROMB HAEM, 83(6), 2000, pp. 944-948

Authors: Hoibraaten, E Os, I Seljeflot, I Andersen, TO Hofstad, AE Sandset, PM

Citation: E. Hoibraaten et al., The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: Results from the estrogen in women with atherosclerosis study, THROMB RES, 98(1), 2000, pp. 19-27

Authors: Hofstad, AE Os, I Abdelnoor, M Platou, ES Westheim, A

Citation: Ae. Hofstad et al., Evidence of excess hereditary predisposition in women with angiographically documented coronary artery disease, CARDIOLOGY, 90(4), 1998, pp. 249-252